Onions: the trials tested powder, extract and capsules

Every benefit anyone can point to for onions was measured on something you cannot buy in the vegetable aisle. A meta-analysis of 14 randomised trials found onion supplementation improved body fat, LDL, total cholesterol, blood pressure and liver enzymes, and its own subgroup analysis puts the effects at doses above 300 mg a day of supplement, over more than 12 weeks. That is a capsule regimen. Nothing in it tested an onion in a meal. Below that, the picture gets thinner still. A double-blind crossover trial gave 162 mg a day of quercetin from onion skin extract to people with raised blood pressure. It found no effect on any measure in the group as a whole. A 3.9 mmHg difference appeared in the hypertensive subgroup at p equal to 0.049, and not one of the mechanisms the authors expected to explain it actually moved. Twelve weeks of 9 g a day of onion powder, which by our own arithmetic works out at roughly a small onion of solids, did not shrink visceral fat either. That was the primary outcome and it was null.

The numbers, per 100 g

What your body absorbs

• Quercetin from onion reaches the blood four times better than the same dose from apple peel. — healthy volunteers, eight women and eight men (n = 16) Evidence B source
  Onion powder gave a peak plasma concentration of 273.2 ± 93.7 ng/mL at 2.0 ± 1.7 hours with a half-life of 14.8 ± 4.8 hours, while apple peel gave 63.8 ± 22.4 ng/mL at 2.9 ± 2.0 hours with a half-life of 65.4 ± 80.0 hours; the mixture fell in between; no gender difference appeared in absorption, though elimination half-time differed by gender

What cooking and storage change

• Whole onion skin powder delivered more quercetin than an extract made from it. — rats in the main comparison, with a confirmatory human ingestion study Evidence D source
  The peel powder meal raised plasma quercetin significantly more than peel extract, bulb powder, bulb extract or sauteed bulb at every period tested; the human study confirmed the superiority of peel powder over peel extract; the difference in log P for quercetin aglycone between powder and extract indicated that the food matrix improves its bioavailability; the effect of processing applied to the peel and not to the bulb

Safety, limits and interactions

• Of all the fermentable carbohydrates, the type onions carry was among the two that brought symptoms back, and onion itself was never the test substance. — patients with irritable bowel syndrome; 45 enrolled, 25 improved on elimination, 21 continued into reintroduction (n = 45 enrolled, 21 in reintroduction) Evidence B source
  Fructans and galacto-oligosaccharides were both associated with worsened abdominal pain (P = .007 and P = .04); galacto-oligosaccharides were associated with increased bloating (P = .03); both bloating and abdominal pain worsened throughout the study regardless of which FODMAP was reintroduced

What people believe that the data does not support

• Pooling the studies, people who ate the most onions and garlic did not get less cancer. — participants in 22 studies with 25 reports on allium vegetables and 10 studies with 11 reports on garlic supplements (n = 32 studies) Evidence A source
  High consumption of allium vegetables showed no significant association with cancer risk, relative risk 0.97 (95% CI 0.92 to 1.03); garlic supplements likewise showed no significant association, relative risk 0.97 (95% CI 0.84 to 1.12); the dose-response analysis was flat, with P for nonlinearity 0.958 and P for linearity 0.907
• Pooled onion trials show metabolic benefit, and the dose where it appears is a supplement dose. — participants in 14 eligible randomised controlled trials (n = 14 trials) Evidence A source
  The crude analysis found significant improvement in body fat percentage, LDL cholesterol, total cholesterol, HDL cholesterol, systolic blood pressure, adiponectin and aspartate aminotransferase; interventions longer than 12 weeks significantly altered weight, waist circumference, body mass index, body fat percentage, LDL, total cholesterol and both blood pressures; doses above 300 mg per day improved the same set plus HDL, ALT and diastolic pressure

What is still unknown

• Onion skin quercetin did not move blood pressure in the trial as a whole, only in the people who already had hypertension. — overweight to obese patients with pre-hypertension and stage I hypertension (n = 70) Evidence B source
  In the total group quercetin did not significantly affect any 24-hour ambulatory or office blood pressure parameter; in the hypertensive subgroup 24-hour systolic pressure fell by 3.6 mmHg (P = 0.022) with a mean treatment difference against placebo of 3.9 mmHg (P = 0.049); endothelin-1, adhesion molecules, ADMA, ACE activity, endothelial function and markers of oxidation, inflammation, lipids and glucose were all unaffected
• Twelve weeks of onion powder did not shrink anyone's visceral fat. — healthy Japanese adults with body mass index at or above 23 and below 30 (n = 70) Evidence B source
  No significant difference in visceral fat area appeared between the groups; in the subgroup whose HDL cholesterol was lower, visceral fat area was significantly lower in the onion group, and alanine aminotransferase was significantly lower in the onion group than in placebo

The bottom line

The absorption finding is the one that survives all of this, and it is about form rather than benefit. Sixteen people took about 100 mg of quercetin as onion powder or as apple peel powder. Onion gave a peak plasma concentration of 273.2 ng/mL against 63.8 from apple peel. Quercetin in onion sits as glucosides that the small intestine can handle, and the apple carries forms it cannot, so the milligrams printed in a composition table are not what arrives in the blood. A related study points the same way from the other end: onion skin powder delivered more quercetin than an extract made from that same skin, and the main dose comparison was done in rats with only a confirmatory arm in people. Concentrating a compound out of its food can lower how much of it gets in. Two popular beliefs did not hold up. Pooling 22 studies on allium vegetables and 10 on garlic supplements, high consumption showed no association with cancer risk, with a relative risk of 0.97 and a flat dose-response. These are observational studies, so a real effect could be hidden by how badly people recall what they eat, and cancer as a whole can conceal a specific site behaving differently. What it does correct is the gap between a large laboratory literature on allium compounds and cancer cells and the absence of any signal in people. If you have been diagnosed with irritable bowel syndrome, onions are a reasonable suspect and a testable one. In a blinded reintroduction study, fructans and galacto-oligosaccharides were the two fermentable carbohydrates associated with worse abdominal pain, and onion is a leading fructan source. Twenty-one patients reached that phase, onion itself was never the test substance, and symptoms drifted worse no matter which sugar was given back, which is what you would expect if expectation were doing some of the work. This applies to people with a diagnosis and to nobody else, and cutting onions out on a hunch is how people end up with shorter diets and the same symptoms. So the honest advice is short. Eat onions because they make food taste like something. If you want what the trials measured, you are looking at capsules above 300 mg a day for three months, tested on markers rather than on anything that happened to anyone. That is a decision to take with a doctor rather than from a shelf.

Sources

1. oni-dr-01 · randomised pharmacokinetic crossover study
   Consumption of the OP led to faster absorption, higher concentration, and greater bioavailability as compared to the AP.
   J Agric Food Chem, 2012 · checked 2026-09-22
2. oni-dr-02 · animal feeding study with human confirmation
   The intake of a peel powder-containing meal provided a significantly higher increase of plasma quercetin concentration than the peel extract, bulb powder, bulb extract, and bulb sauté containing meals at each period tested.
   J Food Sci, 2015 · checked 2026-09-22
3. oni-dr-06 · blinded randomised reintroduction trial
   Fructans and galacto-oligosaccharides (GOS) both were associated with worsened abdominal pain (P = .007 and P = .04, respectively).
   Clin Gastroenterol Hepatol, 2025 · checked 2026-09-22
4. oni-dr-05 · systematic review and meta-analysis of observational studies
   In a pooled analysis of 22 studies with 25 reports on allium vegetables, a high consumption of allium vegetables showed no significant association with cancer risk (relative risk [RR] = 0.97, 95% confidence interval [CI] 0.92-1.03) in a fixed-effects model.
   Front Nutr, 2021 · checked 2026-09-22
5. oni-dr-07 · systematic review and meta-analysis of randomised controlled trials
   Moreover, the intake of dosages of >300 mg/day of onion supplementation could significantly improve weight, WC, BMI, BFP, LDL-c, HDL-C, TC, AST, ALT, SBP and DBP.
   Clin Nutr ESPEN, 2023 · checked 2026-09-22
6. oni-dr-03 · randomised double-blinded placebo-controlled cross-over trial
   In the total group, quercetin did not significantly affect 24 h ABP parameters and office BP.
   Br J Nutr, 2015 · checked 2026-09-22
7. oni-dr-04 · randomised double-blind placebo-controlled parallel-group trial
   No significant differences in visceral fat area (VFA) were observed between the two groups.
   Nutrients, 2019 · checked 2026-09-22